Rhabdoid tumor of the central nervous system

The incidence of tuberculosis in patients treated with certolizumab pegol across indications: impact of baseline skin test results, more stringent screening criteria and geographic region.

RMD open·2015

Dose escalation of certolizumab pegol from 200 mg to 400 mg every other week provides no additional efficacy in rheumatoid arthritis: an analysis of individual patient-level data.

Arthritis and rheumatism·2011

Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations.

Arthritis and rheumatism·2008

Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations.

Annals of the rheumatic diseases·2008

Evaluating the adequacy of disease control in patients with rheumatoid arthritis: a RAND appropriateness panel.

Rheumatology (Oxford, England)·2008

Safety of the selective costimulation modulator abatacept in rheumatoid arthritis patients receiving background biologic and nonbiologic disease-modifying antirheumatic drugs: A one-year randomized, placebo-controlled study.

Arthritis and rheumatism·2006

Malawi pilot study of Burkitt lymphoma treatment.

Medical and pediatric oncology·2003

Epigenetic changes in the DAP-kinase CpG island in pediatric lymphoma.

Medical and pediatric oncology·2003

Differences in vasculature between pilocytic and anaplastic astrocytomas of childhood.

Medical and pediatric oncology·2003

The History of Neurosurgery at New York Medical College and Westchester Medical Center.

Neurosurgery·2026

Persisting Region-Specific Microglia Activation and Synaptic Imbalance During Remission in a DSS-Induced Colitis Model.

Glia·2026

Microbial phenolic metabolites at the neurovascular interface: a precision-nutrition framework for brain aging.

Frontiers in nutrition·2026

Association between corpus callosum microstructure and upper limb motor outcome in moderate-to-severe ischemic stroke patients at 3-6 months post-stroke.

Frontiers in neurology·2026

[Transcranial magnetic stimulation in non-psychiatric disorders].

Ugeskrift for laeger·2026

Ribosomal protein S3: a critical regulator of human disease mechanisms.

Bioscience reports·2026

Related Experiment Videos

Rhabdoid tumor of the central nervous system

Related Concept Videos

The incidence of tuberculosis in patients treated with certolizumab pegol across indications: impact of baseline skin test results, more stringent screening criteria and geographic region.

Dose escalation of certolizumab pegol from 200 mg to 400 mg every other week provides no additional efficacy in rheumatoid arthritis: an analysis of individual patient-level data.

Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations.

Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations.

Evaluating the adequacy of disease control in patients with rheumatoid arthritis: a RAND appropriateness panel.

Safety of the selective costimulation modulator abatacept in rheumatoid arthritis patients receiving background biologic and nonbiologic disease-modifying antirheumatic drugs: A one-year randomized, placebo-controlled study.

Malawi pilot study of Burkitt lymphoma treatment.

Epigenetic changes in the DAP-kinase CpG island in pediatric lymphoma.

Differences in vasculature between pilocytic and anaplastic astrocytomas of childhood.

The History of Neurosurgery at New York Medical College and Westchester Medical Center.

Persisting Region-Specific Microglia Activation and Synaptic Imbalance During Remission in a DSS-Induced Colitis Model.

Microbial phenolic metabolites at the neurovascular interface: a precision-nutrition framework for brain aging.

Association between corpus callosum microstructure and upper limb motor outcome in moderate-to-severe ischemic stroke patients at 3-6 months post-stroke.

[Transcranial magnetic stimulation in non-psychiatric disorders].

Ribosomal protein S3: a critical regulator of human disease mechanisms.

Related Experiment Videos

Rhabdoid tumor of the central nervous system

Related Concept Videos

Related Articles